Some believe that aspirin and similar drugs can provide simple protection against bowel cancer. A large study from China now shows that this hope is unlikely to be fulfilled.
Nabta Health, the Dubai-based hybrid healthcare company positions women not as a niche market but as the starting point for a broader overhaul of preventive medicine.
Asianet Newsable on MSN
Agilent stock slips premarket: $950M Biocare buyout fails to lift investor sentiment after Q1 miss
Agilent expects the deal to boost revenue growth and margins in the first year, with the transaction projected to add to earnings per share about 12 months after closing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results